Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy

被引：0
|
作者：
Kang, Zhihua
Fu, Pan
Ma, Hui
Li, Tao
Lu, Kevin
Liu, Juan
Ginjala, Vasudeva
Romanienko, Peter
Feng, Zhaohui
Guan, Ming
Ganesan, Shridar
Xia, Bing
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7106
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2
    Devkota, Kanchan
    Lohse, Brian
    Liu, Qing
    Wang, Ming-Wei
    Staerk, Dan
    Berthelsen, Jens
    Clausen, Rasmus Praetorius
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (04): : 293 - 297
  • [2] Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2
    Leenders, Ruben
    Zijlmans, Remco
    van Bree, Bart
    van de Sande, Marc
    Trivarelli, Federica
    Damen, Eddy
    Wegert, Anita
    Mueller, Daniel
    Ehlert, Jan Erik
    Feger, Daniel
    Heidemann-Dinger, Carolin
    Kubbutat, Michael
    Schaechtele, Christoph
    Lenstra, Danny C.
    Mecinovic, Jasmin
    Mueller, Gerhard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (17) : 2516 - 2524
  • [3] EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
    Renneville, Aline
    Van Galen, Peter
    Canver, Matthew C.
    McConkey, Marie
    Krill-Burger, John M.
    Dorfman, David M.
    Holson, Edward B.
    Bernstein, Bradley E.
    Orkin, Stuart H.
    Bauer, Daniel E.
    Ebert, Benjamin L.
    BLOOD, 2015, 126 (16) : 1930 - 1939
  • [4] Analogues of the natural product Sinefungin as potent inhibitors of EHMT1 and EHMT2
    Kanchan Devkota
    Brian Lohse
    Qing Liu
    Ming-Wei Wang
    Jens Berthelsen
    Rasmus Prætorius Clausen
    Epigenetics & Chromatin, 6 (Suppl 1)
  • [5] EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
    Nachiyappan, Alamelu
    Gupta, Neelima
    Taneja, Reshma
    FEBS JOURNAL, 2022, 289 (05) : 1329 - 1351
  • [6] TNFa Effects on Adipocytes Are Influenced by the Presence of Lysine Methyltransferases, G9a (EHMT2) and GLP (EHMT1)
    Able, Ashley A.
    Richard, Allison J.
    Stephens, Jacqueline M.
    BIOLOGY-BASEL, 2023, 12 (05):
  • [7] EHMT2 is a metastasis regulator in breast cancer
    Ryu, Tae Young
    Kim, Kwangho
    Son, Mi-Young
    Kim, Dae-Soo
    Cho, Hyun-Soo
    CANCER SCIENCE, 2018, 109 : 1242 - 1242
  • [8] Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma
    Souza, Barbara Kunzler
    Freire, Natalia Hogetop
    Monteiro, Thiago Santos
    Herlinger, Alice Laschuk
    Jaeger, Mariane
    Dalmolin, Matheus G. S.
    de Farias, Caroline Brunetto
    Gregianin, Lauro
    Brunetto, Andre T.
    Brunetto, Algemir L.
    Thiele, Carol J.
    Roesler, Rafael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
  • [9] De novo methylation of histone H3K23 by the methyltransferases EHMT1/GLP and EHMT2/G9a
    Vinson, David A.
    Stephens, Kimberly E.
    O'Meally, Robert N.
    Bhat, Shri
    Dancy, Blair C. R.
    Cole, Robert N.
    Yegnasubramanian, Srinivasan
    Taverna, Sean D.
    EPIGENETICS & CHROMATIN, 2022, 15 (01)
  • [10] MDC1 methylation mediated by lysine methyltransferases EHMT1 and EHMT2 regulates active ATM accumulation flanking DNA damage sites
    Sugiko Watanabe
    Makoto Iimori
    David Virya Chan
    Eiji Hara
    Hiroyuki Kitao
    Yoshihiko Maehara
    Scientific Reports, 8
12345